These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of urocortins in the cardiovascular system. Walczewska J; Dzieza-Grudnik A; Siga O; Grodzicki T J Physiol Pharmacol; 2014 Dec; 65(6):753-66. PubMed ID: 25554979 [TBL] [Abstract][Full Text] [Related]
6. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Simopoulos C; Christodoulou E; Lambropoulou M; Tsaroucha AK; Kakolyris S; Polychronidis A; Karayiannakis AJ; Chatzaki E Neuroendocrinology; 2009; 89(3):315-26. PubMed ID: 19096201 [TBL] [Abstract][Full Text] [Related]
7. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982 [TBL] [Abstract][Full Text] [Related]
8. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Hillhouse EW; Grammatopoulos DK Endocr Rev; 2006 May; 27(3):260-86. PubMed ID: 16484629 [TBL] [Abstract][Full Text] [Related]
10. CRH-R2 signalling modulates feeding and circadian gene expression in hypothalamic mHypoA-2/30 neurons. Alcántara-Alonso V; Dallmann R; Lehnert H; de Gortari P; Grammatopoulos DK Front Endocrinol (Lausanne); 2023; 14():1266081. PubMed ID: 37900150 [TBL] [Abstract][Full Text] [Related]
11. Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour. Hillhouse EW; Grammatopoulos DK Stress; 2001 Dec; 4(4):235-46. PubMed ID: 22432144 [TBL] [Abstract][Full Text] [Related]
12. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255 [TBL] [Abstract][Full Text] [Related]
14. Corticotropin releasing hormone and the skin. Slominski A; Zbytek B; Zmijewski M; Slominski RM; Kauser S; Wortsman J; Tobin DJ Front Biosci; 2006 Sep; 11():2230-48. PubMed ID: 16720310 [TBL] [Abstract][Full Text] [Related]
15. Expression of CRH, CRH-related peptide and CRH receptor in the ovary and potential CRH signalling pathways. Wypior G; Jeschke U; Kurpisz M; Szekeres-Bartho J J Reprod Immunol; 2011 Jun; 90(1):67-73. PubMed ID: 21696829 [TBL] [Abstract][Full Text] [Related]
16. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells. Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771 [TBL] [Abstract][Full Text] [Related]